# Eradication of Helicobacter Pylori in the Management of Stage IE & IIE-1 Primary Low-grade B Cell Lymphoma of MALToma

> **NCT00201422** · NA · COMPLETED · sponsor: **National Health Research Institutes, Taiwan** · enrollment: 70 (actual)

## Conditions studied

- MALT Lymphoma

## Interventions

- **OTHER:** Omeprazole, Amoxicillin, Clarithromycin

## Key facts

- **NCT ID:** NCT00201422
- **Lead sponsor:** National Health Research Institutes, Taiwan
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1996-06
- **Primary completion:** 2004-01
- **Final completion:** 2004-01
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2016-03-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00201422

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00201422, "Eradication of Helicobacter Pylori in the Management of Stage IE & IIE-1 Primary Low-grade B Cell Lymphoma of MALToma". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00201422. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*